• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Syst Rev . COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-ana

tetano

Editor, Senior Moderator
Syst Rev


. 2024 Jul 19;13(1):189.
doi: 10.1186/s13643-024-02597-y. COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-analysis

Qiuying Zhang[SUP] #[/SUP][SUP] 1 [/SUP], Lirui Jiao[SUP] #[/SUP][SUP] 2 [/SUP], Qiushi Chen[SUP] 3 [/SUP], Caroline A Bulstra[SUP] 4 5 6 [/SUP], Pascal Geldsetzer[SUP] 7 8 [/SUP], Tulio de Oliveira[SUP] 9 10 [/SUP], Juntao Yang[SUP] 1 [/SUP], Chen Wang[SUP] 11 [/SUP], Till Bärnighausen[SUP] #[/SUP][SUP] 4 [/SUP], Simiao Chen[SUP] #[/SUP][SUP] 12 13 [/SUP]



Affiliations
Abstract

Background: The COVID-19 pandemic has caused a large mortality and morbidity burden globally. For individuals, a strong immune response is the most effective means to block SARS-CoV-2 infection. To inform clinical case management of COVID-19, development of improved vaccines, and public health policy, a better understanding of antibody response dynamics and duration following SARS-CoV-2 infection and after vaccination is imperatively needed.
Methods: We systematically analyzed antibody response rates in naturally infected COVID-19 patients and vaccinated individuals. Specifically, we searched all published and pre-published literature between 1 December 2019 and 31 July 2023 using MeSH terms and "all field" terms comprising "COVID-19" or "SARS-CoV-2," and "antibody response" or "immunity response" or "humoral immune." We included experimental and observational studies that provided antibody positivity rates following natural COVID-19 infection or vaccination. A total of 44 studies reporting antibody positivity rate changes over time were included.
Results: The meta-analysis showed that within the first week after COVID-19 symptom onset/diagnosis or vaccination, antibody response rates in vaccinated individuals were lower than those in infected patients (p < 0.01), but no significant difference was observed from the second week to the sixth month. IgG, IgA, and IgM positivity rates increased during the first 3 weeks; thereafter, IgG positivity rates were maintained at a relatively high level, while the IgM seroconversion rate dropped.
Conclusions: Antibody production following vaccination might not occur as quickly or strongly as after natural infection, and the IgM antibody response was less persistent than the IgG response.

Keywords: Antibody response; COVID-19; Meta-analysis.

 
Back
Top Bottom